To the Editor: From their observational study,
Dr Vincent and colleagues1 reported that
transfusion was associated with an increased risk of mortality at all hematocrit
levels in a heterogeneous group of critically ill patients. In their accompanying
Editorial, Drs Hébert and Fergusson2 suggested
that this study provides evidence concerning the role of transfusion in patients
with ischemic heart disease. We disagree.
Rathore SS, Krumholz HM. Blood Transfusions and Mortality Among Critically Ill PatientsBlood Transfusions and Mortality Among Critically Ill Patients. JAMA. 2003;289(10):1242–1243. doi:10.1001/jama.289.10.1242-a
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: